Literature DB >> 15538093

New-onset diabetes in the hypertension treatment trials: a point of view.

Marvin Moser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15538093     DOI： 10.1111/j.1524-6175.2004.03903.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  8 in total

Review 1.  New-onset diabetes in treated hypertensive patients.

Authors:  Paolo Verdecchia; Fabio Angeli; Gian Paolo Reboldi; Roberto Gattobigio
Journal:  Curr Hypertens Rep       Date:  2005-06       Impact factor: 5.369

2.  In search of true value.

Authors:  William J Kostis; Alan C Wilson
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-03       Impact factor: 3.738

3.  The ASCOT trial.

Authors:  Marvin Moser
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-12       Impact factor: 3.738

Review 4.  Is new-onset diabetes of clinical significance in treated hypertensive patients?--Con.

Authors:  Marvin Moser
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-02       Impact factor: 3.738

Review 5.  Is the development of diabetes with antihypertensive therapy a problem?--Pro.

Authors:  Paolo Verdecchia; Fabio Angeli; Gianpaolo Reboldi; Roberto Gattobigio
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-02       Impact factor: 3.738

6.  Ten years and counting: the journal of clinical hypertension.

Authors:  Marvin Moser
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-05       Impact factor: 3.738

Review 7.  Pathophysiologic, diagnostic, and therapeutic aspects of the metabolic syndrome.

Authors:  Thomas D Giles; Gary E Sander
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-11       Impact factor: 3.738

Review 8.  Blood pressure control in patients with comorbidities.

Authors:  Roland E Schmieder; Luis M Ruilope
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-08       Impact factor: 3.738
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.